MPN Voice

Ruxolitinib (Jakavi) change to packaging

Novartis Pharmaceuticals UK Limited have informed MPD Voice that as of Friday 16th August 2013, Jakavi (Ruxolitinib) tablets will be packaged in blister packs, the formulation of the tablets will remain the same, it is just the packaging that has changed. If you have any concerns regarding this, in the first instance please speak to the pharmacist where your tablets are dispensed, if you still have concerns please email us at


You may also like...